Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Arev Life Sciences Global Corp.
AREV NANOTEC BRANDS INC. EARLY WARNING REPORT
Published Jul 13 2020
3 min read

AREV NANOTEC BRANDS INC. EARLY WARNING REPORT

July 13, 2020 – Mr. Mike Withrow reports that Chiron Capital Inc. (“Chiron”), a company that Mr. Withrow controls, has acquired ownership, control, and direction over 10,779,000 common shares (the “Shares”) of AREV Nanotec Brands Inc. (the “Company”) representing 60% of the issued and outstanding Shares. The Shares were acquired pursuant to a private placement made in reliance on the private agreement exemption set out in section 4.2 of Multilateral Instrument 62-104 TakeOver Bids and Issuer Bids (“62-104”). As a result of the acquisition of the Shares, Mr. Withrow controls, and Chiron owns, 10,779,000 Shares representing approximately 60% of the issued and outstanding Shares. Chiron has acquired the securities for investment purposes and, as disclosed in the accompanying Early Warning Report, may in the future acquire or dispose of securities of the Company, through the market, privately or otherwise, as circumstances or market conditions warrant. Mr. Withrow and Chiron are accredited investors as defined in NI 45-106. A copy of the Early Warning Report filed with the applicable securities regulators regarding the above acquisition is available on SEDAR (www.sedar.com).


For further information, contact:


Mike Withrow

(778) 896-6536.


The issuance of this news release is not an admission that an entity named in the news release owns or controls any described securities or is a joint actor with another named entity.